The mean expression level of TYRO3 per cell (indicated as MFI) did not show statistical differences in monocytes, but this receptor showed a significantly higher level in DCs of patients with HIMS or HC compared to MS (Fig 1D–1G). This evidence concerns the gene TYRO3 and myeloid sarcoma.